| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785762 | Cancer Treatment Reviews | 2018 | 6 Pages |
Abstract
In renal cancer emerging treatment options are becoming available and there is a strong need to combine therapies to reformulate and adjourn clinical practice. We here highlight and discuss the need to take advantage of the common immune targets to design combined strategies to increase clinical responses.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M. Nuti, I.G. Zizzari, A. Botticelli, A. Rughetti, P. Marchetti,